|

Posters,
Presentations & Publications
For
Presentations and Posters in PDF Adobe
Acrobat Reader is required. If you experience problems downloading
the PDF, see Note in right margin, or we can send an 11x17 hard
copy to you. Please e-mail info@inspirepharm.com
with name, address, & telephone number.
2008
2007
2006
2005
2004 2003 2002 2001 2000 1996-1999
Kellerman
D, Evans R, Mathews D, Shaffer C. Inhaled P2Y2
receptor agonists as a treatment for patients with Cystic Fibrosis
lung disease. Adv Drug Deliv Rev. 2002 Dec 5;54(11):1463-1474.
Johnson
FL, Donohue JF, Shaffer CL. Improved sputum expectoration following
a single dose of INS316 in patients with chronic bronchitis.
Chest. 2002 Dec;122(6): 2021-2029.
Meltzer
EO, Ice JC, LaVange LM, Kellerman DJ, Schaberg AE. INS37217,
a P2Y2 receptor agonist given intranasally,
is well tolerated and decreases saccharin transport time in subjects
with and without perennial allergic rhinitis. Results presented
at the 2002 American College of Allergy, Asthma & Immunology
Annual Meeting. 2002 November 15-20, San Antonio, Texas.
Douglass
J, Patel RI, Redick C, Brubaker K, Jones AC, Shaver SR, Yerxa B,
Baurand A, Gachet C, Boyer JL. Ribose and nucleobase modifications
to nucleotides that confer antagonist properties against the platelet
P2Y12 receptor. Poster
presented at The
Platelet ADP Receptors 2nd International Meeting. 2002 October
3-5; Sardinia, Italy.
Deterding
R, Engels J, Shaffer C Kellerman D Mathews D LaVange L, Gorden J,
Quittner A, Williams J, Ramsey B. Safety
and tolerability of INS37217 inhalation solution, a novel P2Y2
receptor agonist, in patients with mild to moderate cystic fibrosis:
Results of a phase 1/2 multi-center study. Poster presented
at the 2002 North American Cystic Fibrosis Conference. 2002
October 3-6; New Orleans, Louisiana, USA. Poster
in PDF
Deterding
R, Engels J, Shaffer C Kellerman D Mathews D LaVange L, Gorden J,
Quittner A, Williams J, Ramsey B. Safety
and tolerability of INS37217 inhalation solution, a novel P2Y2
receptor agonist, in patients with mild to moderate cystic fibrosis:
Results of a phase 1/2 multi-center study. Powerpoint presentation
by Robin Deterding, MD at the 2002 North American Cystic Fibrosis
Conference. 2002 October 3-6; New Orleans, Louisiana, USA.
Yerxa
BR, Sabater JR, Davis CW, Stutts MJ, Lang-Furr M, Picher M, Jones
AC, Cowlen M, Dougherty R, Boyer J, Abraham WM, Boucher RC. Pharmacology
of INS37217 [P1-(uridine 5')-P4-(2'-deoxycytidine
5')tetraphosphate, Tetrasodium Salt], a next-generation P2Y2
receptor agonist for the treatment of cystic fibrosis. J
Pharmacol Exp Ther, 2002 Sep, 302(3):871-880.
Plourde
R Jr., Brown EG, Pelaez T, Peral A, Peterson W, Yerxa B, Pintor
J. Design of novel melatonin analogs for reduction of intraocular
pressure. Poster presented at IUPHAR 2002 - XIVth
World Congress of Pharmacology. 2002 July 7-12; San Francisco,
California, USA.
Jones
AC, Redick CC, Zhang V, Brubaker K, Patel RI, Boyer JL. Characterization
of 2MeSADP response in wild type 1321N1 human astrocytoma cells.
Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Patel
RI, Douglass J, Redick C, Brubaker K, Jones AC, Shaver SR, Yerxa
B, Boyer JL. Identification of a ribose substitution that confers
antagonist properties to ADP against the platelet P2Y12
receptor. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Cowlen
MS, Bazemore EK, Gomez LM, Yerxa B, Peterson WM, Stutts MJ. P2Y2
receptor gene expression and regulation of short circuit current
(Isc) by P2Y2 receptor
agonists in endocervical epithelial cells. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Zhang
VZ, Yerxa BR, Cowlen MS. Cellular distribution of P2Y2
receptor gene expression in the primate gastrointestinal tract by
in situ hybridization. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Brubaker
KE, Redick C, Patel R, Jones A, Boyer JL. High throughput screening
for agonists and antagonists of ADP receptors. Poster
presented at IUPHAR 2002 - XIVth World
Congress of Pharmacology. 2002 July 7-12; San Francisco, California,
USA.
Douglass
J, Yerxa B, Boyer JL, Redick C, Patel R, Jones A. Dinucleoside
tetraphosphates modified with lipophilic substituents on the ribose
hydroxyls: selected structure-activity relationships at nucleotide
G-protein coupled receptors. Poster presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Boyer
JL, Patel RI, Redick C, Brubaker K, Douglass J, Shaver S, Baurand
A, Gachet C, Yerxa B. Inhibition of platelet aggregation by novel
selective P2Y12 receptor antagonists.
Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Baurand
A, Patel RI, Redick K, Douglass J, Shaver S, Yerxa B, Boyer JL,
Cazenave JP, Gachet C. Reduced thromboembolism in mice treated
with a novel class of P2Y12 receptor antagonists.
Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Crean
C, Douglass J, Yerxa B, Redick K, Patel R, Jones A. Dinucleoside
tetraphosphates with base lipophilic substituent modifications:
selected structure-activity relationships at nucleotide G-protein
coupled receptors. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Gomez
L, Venturini AE, Peterson WM. Profiling the activation of many
intracellular signaling proteins in response to stimulation of P2Y2
receptors using a high-output western blot assay. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Brown EG, Boyer J, Shaver SR. Detection of INS316, INS365 and
other nucleotides in plasma and fluids by LC/MS. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Bednarski
K, Douglass JG, Redick CC, Jones AC, Patel RI, Shaver SR. Modified
nucleoside polyphosphates as platelet aggregation. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Shaver
SR, Douglass JG, Brown EG, Patel RI, Redick CC, Jones AC, Boyer
JL, Picher M, Yerxa BR. P2Y receptor agonists: a comparison of
mixed-base dinucleotides versus same-base dinucleotides and their
deoxyribo-analogues. Poster
presented at IUPHAR
2002 - XIVth World Congress of Pharmacology.
2002 July 7-12; San Francisco, California, USA.
Johnson
FL, Yung RC-W, Sussman R, ZuWallack RL, Kellerman DJ. Improved
lung cancer diagnostic value of sputum induced with a single inhaled
dose of INS316 (uridine 5'-triphosphate). Poster
presented at the
American
Thoracic Society (ATS) 98th International Conference. 2002 May
17-22; Atlanta, Georgia, USA.
Peral
A, Bautista A, Carracedo G, Yerxa BR, Pintor J. Nucleotides and
dinucleotides increase re-epithelialisation in rabbit corneal wounds.
Poster
presented at The
Association for Research in Vision and Ophthalmology (ARVO) 2002
Annual Meeting. 2002 May 5-10; Fort Lauderdale, Florida, USA.
Wen
Q, Li Y, Kuang K, Zuniga FA, Iserovich P, Yerxa B, Fischbarg J.
Effects of P2Y2 agonists on lipid secretion
by cultured rabbit meibocytes. Poster
presented at The
Association for Research in Vision and Ophthalmology (ARVO) 2002
Annual Meeting. 2002 May 5-10; Fort Lauderdale, Florida, USA.
Donshik
PC, Sall KN, Cacioppo LR, Whitsell RN, Mayhew AL, Yerxa BR, Crockett
RS, Kellerman DJ. Presenting symptoms from diary cards for dry
eye clinical trial subjects. Poster
presented at The
Association for Research in Vision and Ophthalmology (ARVO) 2002
Annual Meeting. 2002 May 5-10; Fort Lauderdale, Florida, USA.
Kellerman
DJ. P2Y2 receptor agonists: a new class
of medication targeted at improved mucociliary clearance. Chest.
2002 May;121 (5 Suppl): 201S-205S.
Redick
CC, Jones AC, Zhang V, Brubaker K, Patel RI, Boyer JL. Endogenous
expression of P2Y1 receptors in 1321N1
human astrocytoma cells. Poster
presented at the
Federation
of American Societies for Experimental Biology Annual Meeting.
2002 April 20-24; New Orleans, Louisiana, USA.
Pintor
J, Peral A, Hoyle C, Redick C, Douglass J, Yerxa B. Effects of
diadenosine polyphosphates on tear secretion in New Zealand white
rabbits. J Pharmacol Exp Ther, 2002 Jan, 300(1):291-297.
Pendergast
W and Evans R. P2Y Receptor Agonists: Role in Mucosal Hydration
and Mucociliary Clearance. New Drugs for Asthma, Allergy
and COPD, 2002, 31(5):165-168.
Yerxa
BR, Mundasad M, Sylvester RN, Garden JC, Cooper M, Kellerman DJ.
Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist,
in patients with mild to moderate dry eye disease. Adv Exp
Med Biol. 2002; 506(Pt B): 1251-1257.
Yerxa
BR. Industry perspective. Adv Exp Med Biol. 2002;506
(Pt B):1343-1344.
Yerxa
BR, Douglass JG, Elena PP, Caillaud T, Amar T, Edick C, Peterson
WM. Potency and duration of action of synthetic P2Y2
receptor agonists on Schirmer scores in rabbits. Adv Exp
Med Biol. 2002;506 (Pt A): 261-265.
Page
last updated: 23-Jun-2008
|
|
|
|
|
|
Copyright
© 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved
|
|
|
|